Biohaven Pharmaceuticals

Discussion in 'Biohaven' started by anonymous, Sep 6, 2019 at 2:25 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Who else has a crazy manager? I don’t paid enough to put up with his crap. Gotta get out before it gets any worse, still in the field with all this Covid. It’s embarrassing
     

  2. anonymous

    anonymous Guest

    Mine is definitely nuts. She calls me Django, and always wants to play massa has left the family and gone to to the store.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    Heard layoffs in January. Your manager won’t tell you anything but inside source says less reps to cut costs. Good luck out there. Too many of you.. can’t keep giving away product and pay ya’ll.
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    Bullshit
     
  7. anonymous

    anonymous Guest

    Right. Because what could possibly be wrong with a business model that gives away the farm on a new drug and has territories only producing 20-30 Rx's a week staffed by 2 reps making $110,000+, plus bonus, plus car, plus benefits.

    That can go on forever. Like Celine Dion's heart in Titanic.
     
  8. anonymous

    anonymous Guest

    on the investor call they said operating costs were $42M per quarter and $17M in revenue. Also took loss of $195M in Q3 alone. These are facts. They can be verified. They have to monetize this drug in January, wait for it. Well be doing PAs like crazy to make money. That’s why even if you are generating scripts your manager is like you still need to get PAs done even at $0 copay. They are losing money every script they use the access card with.
     
  9. anonymous

    anonymous Guest

    UGH we've been lulled in the NRX/TRX scenario market share story which sounds all too great but the bottom line is in the DOLLAR PROFIT.
     
  10. anonymous

    anonymous Guest

    Time to anty up. We’ve given drug away for too long. Get ready to tell customers they need to do the work now. Ha. Yeah.. there will be layoffs coming.
     
  11. anonymous

    anonymous Guest

    from who?
     
  12. anonymous

    anonymous Guest

    what is anty up
     
  13. anonymous

    anonymous Guest

    Layoffs on way. Certainty
     
  14. anonymous

    anonymous Guest

    Please, this same old song every year!!! No layoffs are coming, so shut the frick up ass-wipe.
     
  15. anonymous

    anonymous Guest

    Live in your dream world. Layoffs. This drug is being given away. It’s Over. Too many reps. High cost. Get your head out of your ass. Get your resume dusted off . Good luck finding a job now.
     
  16. anonymous

    anonymous Guest

    Expect to see the ‘as low as $0’ offer move up to $5 or $10. That extra $5 to $10 actually makes a big difference in the gross to net number. Anyplace the brand team can scale back they will investigate.

    basically it’s a ‘bait and switch’ scenario. Get patients in product for ‘free’ (even though their employer AND BHVN pick up majority of the cost.). Now the patients are on and you can slowly peel back on the max benefit for the card (reduce monthly max $ benefit, push copay UP to $10, etc). People with migraines will pay $10 for the drug if it keeps their heads feeling better.
     
  17. anonymous

    anonymous Guest

    Yeah.. let’s try to explain all that to customers. They are going to love the bait and switch .. layoffs on way.. not all reps can keep jobs with this environment for at least 6 more months. Customers already shutting doors and we keep trying to knock on them. Now tell them they have to do more work.. righttttt
     
  18. anonymous

    anonymous Guest

    Nice TV commercial with Khole K. SMH
     
  19. anonymous

    anonymous Guest


    Oral or topical administration?
     
  20. anonymous

    anonymous Guest

    Good for appealing to white trash